Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 396 articles:
HTML format



Single Articles


    July 2021
  1. GOLOVICS PA, Gonczi L, Reinglas J, Verdon C, et al
    Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study.
    Dig Dis Sci. 2021 Jul 20. pii: 10.1007/s10620-021-07178.
    PubMed     Abstract available


  2. KIM ES, Kim KO, Jang BI, Kim EY, et al
    Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2021 Jul 14. pii: 10.1007/s10620-021-07130.
    PubMed     Abstract available


  3. RAO S, Borum ML
    Evaluating IBD Patient-Initiated Electronic Communication During the SARS-CoV-2 Pandemic: A Single-Center Study.
    Dig Dis Sci. 2021;66:2468-2469.
    PubMed    


    June 2021
  4. PAULIDES E, Pasma A, Erler NS, van Eijk RLA, et al
    Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07118.
    PubMed     Abstract available


  5. PAREKH R, Zhang X, Ungaro RC, Brenner EJ, et al
    Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07104.
    PubMed     Abstract available


  6. BHAT S, Limdi JK, Cross RK, Farraye FA, et al
    Does Similarity Breed Contempt? A Review of the Use of Biosimilars in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07114.
    PubMed     Abstract available


  7. GRANDMOUGIN A, D'Amico F, Remen T, Danese S, et al
    Role of Cross-Sectional Imaging in Pediatric Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 22. pii: 10.1007/s10620-021-07016.
    PubMed     Abstract available


  8. FAWSON S, Dibley L, Smith K, Batista J, et al
    Developing an Online Program for Self-Management of Fatigue, Pain, and Urgency in Inflammatory Bowel Disease: Patients' Needs and Wants.
    Dig Dis Sci. 2021 Jun 19. pii: 10.1007/s10620-021-07109.
    PubMed     Abstract available


  9. STONE ML, Feng M, Forster EM
    COVID-19 Pandemic Increased Anxiety Among Patients with Inflammatory Bowel Disease: A Patient Survey in a Tertiary Referral Center.
    Dig Dis Sci. 2021 Jun 11. pii: 10.1007/s10620-021-07095.
    PubMed     Abstract available


  10. MCCURDY JD, Ellen Kuenzig M, Spruin S, Fung OW, et al
    Surgery and the Subtype of Inflammatory Bowel Disease Impact the Risk of Venous Thromboembolism After Hospital Discharge.
    Dig Dis Sci. 2021 Jun 10. pii: 10.1007/s10620-021-07064.
    PubMed     Abstract available


  11. ISHIHARA J, Arai K, Kudo T, Nambu R, et al
    Serum Zinc and Selenium in Children with Inflammatory Bowel Disease: A Multicenter Study in Japan.
    Dig Dis Sci. 2021 Jun 8. pii: 10.1007/s10620-021-07078.
    PubMed     Abstract available


    May 2021
  12. EMERSON C, Fuller-Tyszkiewicz M, Orr R, Lyall K, et al
    Low Subjective Wellbeing Is Associated with Psychological Distress in People Living with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 May 29. pii: 10.1007/s10620-021-07065.
    PubMed     Abstract available


  13. AL KHOURY A, Balram B, Bessissow T, Afif W, et al
    Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review.
    Dig Dis Sci. 2021 May 21. pii: 10.1007/s10620-021-07025.
    PubMed     Abstract available


  14. CARON B, Neuville E, Peyrin-Biroulet L
    Inflammatory Bowel Disease and COVID-19 Vaccination: A Patients' Survey.
    Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07040.
    PubMed     Abstract available


  15. SYED A, Seoud T, Carleton NM, Thakkar S, et al
    Association Between Portal Vein Thrombosis and Pouchitis in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 May 4. pii: 10.1007/s10620-021-06969.
    PubMed     Abstract available


  16. JOGENDRAN R, Tandon P, Kroeker KI, Dieleman LA, et al
    A Dedicated Pregnancy Clinic Improves Reproductive Knowledge in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-06998.
    PubMed     Abstract available


  17. HAO Y, Yzet C, McBride RB, Stock A, et al
    Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis.
    Dig Dis Sci. 2021 May 2. pii: 10.1007/s10620-021-06970.
    PubMed     Abstract available


  18. WEN T, Faye AS, Lee KE, Friedman AM, et al
    Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months.
    Dig Dis Sci. 2021 May 1. pii: 10.1007/s10620-021-06999.
    PubMed     Abstract available


  19. KOCHAR BD, Cai W, Ananthakrishnan AN
    Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty.
    Dig Dis Sci. 2021 May 1. pii: 10.1007/s10620-021-06990.
    PubMed     Abstract available


    April 2021
  20. DAI C, Huang YH
    Letter to the Editor on "Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease Patients During the SARS-CoV-2 Pandemic".
    Dig Dis Sci. 2021 Apr 29. pii: 10.1007/s10620-021-06957.
    PubMed    


    March 2021
  21. SOO WT, Costello SP, Bryant RV
    Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Mar 25. pii: 10.1007/s10620-021-06946.
    PubMed    


  22. BARBER GE, Hendler S, Choe M, Keyashian K, et al
    Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Mar 23. pii: 10.1007/s10620-021-06947.
    PubMed     Abstract available


  23. HONAP S, Meade S, Ibraheim H, Irving PM, et al
    Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021 Mar 16. pii: 10.1007/s10620-021-06932.
    PubMed     Abstract available


  24. BAMIAS G, Kokkotis G, Gizis M, Kapizioni C, et al
    Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort.
    Dig Dis Sci. 2021 Mar 9. pii: 10.1007/s10620-021-06907.
    PubMed     Abstract available


  25. PERISETTI A, Goyal H
    Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic.
    Dig Dis Sci. 2021 Mar 3. pii: 10.1007/s10620-021-06874.
    PubMed     Abstract available


    February 2021
  26. BASIL M, Schwartz D, Dalal R, Horst S, et al
    Mucosal Integrity Testing Can Detect Differences in the Rectums of Patients with Inflammatory Bowel Disease Compared to Controls: A Pilot Study.
    Dig Dis Sci. 2021 Feb 27. pii: 10.1007/s10620-021-06888.
    PubMed     Abstract available


  27. MONTENEGRO ML, Corral JE, Lukens FJ, Ji B, et al
    Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 24. pii: 10.1007/s10620-021-06899.
    PubMed     Abstract available


  28. LUO W, Tian L, Tan B, Shen Z, et al
    Update: Innate Lymphoid Cells in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 20. pii: 10.1007/s10620-021-06831.
    PubMed     Abstract available


  29. VERMA A, Varma S, Freedberg DE, Axelrad JE, et al
    A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 19. pii: 10.1007/s10620-021-06877.
    PubMed     Abstract available


  30. LLANOS-CHEA A, Shapiro JM, Winter RW, Jerger L, et al
    Lymphoma in Pediatric-Onset Inflammatory Bowel Disease Treated with Infliximab Monotherapy: A Case Series.
    Dig Dis Sci. 2021 Feb 17. pii: 10.1007/s10620-021-06884.
    PubMed     Abstract available


  31. DALAL RS, Ananthakrishnan AN, Hamilton MJ, Winter RW, et al
    Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab.
    Dig Dis Sci. 2021 Feb 11. pii: 10.1007/s10620-021-06852.
    PubMed    


  32. BARSKY M, Meserve J, Le H, Collins A, et al
    Correction to: Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06879.
    PubMed    


  33. SHIRAISHI K, Furukawa S, Yagi S, Mori K, et al
    Serum Globulin Is Associated with Endoscopic Findings and Mucosal Healing in Japanese Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 Feb 4. pii: 10.1007/s10620-021-06834.
    PubMed     Abstract available


  34. JAGT JZ, Pothof CD, Buiter HJC, van Limbergen JE, et al
    Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study.
    Dig Dis Sci. 2021 Feb 3. pii: 10.1007/s10620-021-06836.
    PubMed     Abstract available


  35. QI Y, Wu HM, Yang Z, Zhou YF, et al
    New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 1. pii: 10.1007/s10620-021-06837.
    PubMed     Abstract available


  36. GAIDOS JKJ, Kane SV
    Medication Adherence During Pregnancy in IBD: Compliance Avoids Complications.
    Dig Dis Sci. 2021;66:336-337.
    PubMed    


  37. AGRAWAL G, Aitken J, Hamblin H, Collins M, et al
    Putting Crohn's on the MAP: Five Common Questions on the Contribution of Mycobacterium avium subspecies paratuberculosis to the Pathophysiology of Crohn's Disease.
    Dig Dis Sci. 2021;66:348-358.
    PubMed     Abstract available


  38. NIV E, Ovadia B, Groisman G, Kopelman Y, et al
    CMV-Induced Severe Colonic Stricture in an Adult Crohn's Disease Patient.
    Dig Dis Sci. 2021;66:636-639.
    PubMed    


    January 2021
  39. SINH P, Tabibian JH, Biyani PS, Mehta K, et al
    Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction.
    Dig Dis Sci. 2021 Jan 25. pii: 10.1007/s10620-020-06818.
    PubMed     Abstract available


  40. GRAZIANO F, Macaluso FS, Cassata N, Citrano M, et al
    Rescue Therapy with Intensive Vedolizumab Optimization in a Seventeen-Year-Old Girl with Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2021 Jan 19. pii: 10.1007/s10620-021-06826.
    PubMed    


  41. IBORRA I, Puig M, Marin L, Calafat M, et al
    Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic.
    Dig Dis Sci. 2021 Jan 19. pii: 10.1007/s10620-020-06807.
    PubMed     Abstract available


  42. DEL VALLE JP, Lee GC, Serrato JC, Feuerstein JD, et al
    Recurrence of Clostridium Difficile and Cytomegalovirus Infections in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-Anal Anastomosis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06772.
    PubMed     Abstract available


  43. TOWNSEND CM, Khanna R, Wilson AS
    A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-alpha Antagonists.
    Dig Dis Sci. 2021 Jan 11. pii: 10.1007/s10620-020-06773.
    PubMed     Abstract available


    December 2020
  44. BORREN NZ, Tan W, Jess AT, Li PM, et al
    Assessment of Body Weight Changes in Patients with Inflammatory Bowel Diseases Initiating Biologic Therapy: A Prospective Cohort Study.
    Dig Dis Sci. 2020;65:3672-3678.
    PubMed     Abstract available


  45. GAO XH, Yu GY, Khan F, Li JQ, et al
    Greater Peripouch Fat Area on CT Image Is Associated with Chronic Pouchitis and Pouch Failure in Inflammatory Bowel Diseases Patients.
    Dig Dis Sci. 2020;65:3660-3671.
    PubMed     Abstract available


  46. LUO Y, Tixier EN, Grinspan AM
    Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Dig Dis Sci. 2020;65:3647-3651.
    PubMed     Abstract available


    November 2020
  47. DULAI PS, Jairath V
    A Microsimulation Model to Project the 5-Year Impact of Using Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Acute Flares.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06707.
    PubMed     Abstract available


  48. ZHANG Y, Li X, Li Y, Li Y, et al
    DNA Damage-Regulated Autophagy Modulator 1 (DRAM1) Mediates Autophagy and Apoptosis of Intestinal Epithelial Cells in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06697.
    PubMed     Abstract available


  49. BALRAM B, Joshi H, Wong K, Kroeker KI, et al
    Concomitant 5-Aminosalicylate Therapy in Moderate-to-Severe Ulcerative Colitis Patients Escalated to Infliximab Is Not Beneficial.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06704.
    PubMed     Abstract available


  50. DIBLEY L, Khoshaba B, Artom M, Van Loo V, et al
    Patient Strategies for Managing the Vicious Cycle of Fatigue, Pain and Urgency in Inflammatory Bowel Disease: Impact, Planning and Support.
    Dig Dis Sci. 2020 Nov 8. pii: 10.1007/s10620-020-06698.
    PubMed     Abstract available


  51. AXELRAD JE, Sauk JS
    Gastrointestinal Infections in IBD Flares: Can PCR-Based Stool Tests Differentiate the Smoke from the Fire?
    Dig Dis Sci. 2020;65:3064-3065.
    PubMed    


  52. PASTORELLI L, Bezzio C, Saibeni S
    Hold the Foam: Why Topical Budesonide Remains Relevant for IBD Therapy.
    Dig Dis Sci. 2020;65:3066-3068.
    PubMed    


  53. SINGH M, Singh V, Schurman JV, Friesen CA, et al
    Mucosal Th17 Cells Are Increased in Pediatric Functional Dyspepsia Associated with Chronic Gastritis.
    Dig Dis Sci. 2020;65:3184-3190.
    PubMed     Abstract available


    October 2020
  54. HOURI H, Yadegar A, Zali MR
    How Infection with C. difficile Infection Aggravates Inflammatory Bowel Disease: Is It CDI or the CDAI?
    Dig Dis Sci. 2020 Oct 23. pii: 10.1007/s10620-020-06667.
    PubMed    


  55. SCRIBANO ML
    Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06624.
    PubMed     Abstract available


  56. NGUYEN ALH, Sparrow MP
    Evolving Role of Thiopurines in Inflammatory Bowel Disease in the Era of Biologics and New Small Molecules.
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06662.
    PubMed     Abstract available


  57. KARASKOVA E, Pospisilova D, Velganova-Veghova M, Geryk M, et al
    Importance of Hepcidin in the Etiopathogenesis of Anemia in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06652.
    PubMed     Abstract available


  58. VAN GENNEP S, de Boer NKH, Gielen ME, Rietdijk ST, et al
    Impaired Quality of Working Life in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06647.
    PubMed     Abstract available


  59. SITKIN S, Pokrotnieks J
    Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06650.
    PubMed     Abstract available


  60. PANACCIONE R, Isaacs JD, Chen LA, Wang W, et al
    Correction to: Characterization of Creatine Kinase Levels in TofacitinibTreated Patients with Ulcerative Colitis: Results from Clinical Trials.
    Dig Dis Sci. 2020 Oct 10. pii: 10.1007/s10620-020-06638.
    PubMed     Abstract available


  61. COSTRINI NV
    Clearing of the Clouds in Inflammatory Bowel Disease Management.
    Dig Dis Sci. 2020 Oct 3. pii: 10.1007/s10620-020-06635.
    PubMed     Abstract available


  62. CAPPELL MS
    Improving the Safety of Endoscopy in Pregnancy: Approaching Gravidity with Gravitas.
    Dig Dis Sci. 2020;65:2745-2748.
    PubMed    


  63. WEINGARDEN AR, Smith P, Streett S, Triadafilopoulos G, et al
    A Failure to Communicate: Disentangling the Causes of Perianal Fistulae in Crohn's Disease and Anal Squamous Cell Cancer.
    Dig Dis Sci. 2020;65:2806-2809.
    PubMed    


    September 2020
  64. SMITH R, Hubers J, Farraye FA, Sampene E, et al
    Accuracy of Self-Reported Vaccination Status in a Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Sep 29. pii: 10.1007/s10620-020-06631.
    PubMed     Abstract available


  65. XIU MX, Liu YM, Chen GY, Hu C, et al
    Identifying Hub Genes, Key Pathways and Immune Cell Infiltration Characteristics in Pediatric and Adult Ulcerative Colitis by Integrated Bioinformatic Analysis.
    Dig Dis Sci. 2020 Sep 25. pii: 10.1007/s10620-020-06611.
    PubMed     Abstract available


  66. NOMURA E, Sujino T, Hosoe N, Yoshimatsu Y, et al
    Characteristics of the Mucosal Surface on Scanning Electron Microscopy in Patients with Remitting Ulcerative Colitis.
    Dig Dis Sci. 2020 Sep 21. pii: 10.1007/s10620-020-06609.
    PubMed     Abstract available


  67. BLANEY H, Vu P, Mathew A, Snelling R, et al
    Anemia Severity Associated with Increased Healthcare Utilization and Costs in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Sep 5. pii: 10.1007/s10620-020-06590.
    PubMed     Abstract available


  68. BARSKY M, Meserve J, Le H, Collins A, et al
    Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Sep 1. pii: 10.1007/s10620-020-06568.
    PubMed     Abstract available


  69. BLESL A, Rainer F, Pollheimer M, Kump P, et al
    Successful Pregnancies After Regression of AA Amyloidosis by Anti-inflammatory Therapy in Chronic Active Crohn's Disease.
    Dig Dis Sci. 2020;65:2730-2734.
    PubMed    


  70. HALLE E, Azahaf M, Duveau N, Lambin T, et al
    Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohn's Disease.
    Dig Dis Sci. 2020;65:2664-2674.
    PubMed     Abstract available


  71. CERNOCH PS, Fournier N, Zeitz J, Scharl M, et al
    Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.
    Dig Dis Sci. 2020;65:2654-2663.
    PubMed     Abstract available


    August 2020
  72. MULGUND A, Stein D
    Is Biologic Therapy in Inflammatory Bowel Disease Contributing to the Obesity Epidemic? Just Weight One Year.
    Dig Dis Sci. 2020 Aug 24. pii: 10.1007/s10620-020-06548.
    PubMed    


  73. PANACCIONE R, Isaacs JD, Chen LA, Wang W, et al
    Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials.
    Dig Dis Sci. 2020 Aug 20. pii: 10.1007/s10620-020-06560.
    PubMed     Abstract available


  74. MOKTAN V, Jonica E, Li Z, Hata DJ, et al
    C. difficile and the Patient with Inflammatory Bowel Disease: A Testing Dilemma.
    Dig Dis Sci. 2020 Aug 16. pii: 10.1007/s10620-020-06496.
    PubMed    


  75. LOPEZ RN, Day AS
    The Loneliness of Long-Term Thiopurine Monotherapy for Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Aug 7. pii: 10.1007/s10620-020-06512.
    PubMed    


  76. LAM AY, Gutin LS, Nguyen Y, Velayos FS, et al
    Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2020 Aug 4. pii: 10.1007/s10620-020-06521.
    PubMed    


  77. SCOTT FI
    Infliximab Versus Biosimilars for IBD: Is It Better to Fight Than Switch?
    Dig Dis Sci. 2020;65:2158-2160.
    PubMed    


  78. COATES MD, Seth N, Clarke K, Abdul-Baki H, et al
    Opioid Analgesics Do Not Improve Abdominal Pain or Quality of Life in Crohn's Disease.
    Dig Dis Sci. 2020;65:2379-2387.
    PubMed     Abstract available


    July 2020
  79. PERRY C, Fischer K, Elmoursi A, Kern C, et al
    Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis.
    Dig Dis Sci. 2020 Jul 24. pii: 10.1007/s10620-020-06486.
    PubMed     Abstract available


  80. HIRTEN RP, Stanley S, Danieletto M, Borman Z, et al
    Wearable Devices Are Well Accepted by Patients in the Study and Management of Inflammatory Bowel Disease: A Survey Study.
    Dig Dis Sci. 2020 Jul 23. pii: 10.1007/s10620-020-06493.
    PubMed     Abstract available


  81. XU F, Wheaton AG, Barbour KE, Liu Y, et al
    Trends and Outcomes of Hip Fracture Hospitalization Among Medicare Beneficiaries with Inflammatory Bowel Disease, 2000-2017.
    Dig Dis Sci. 2020 Jul 22. pii: 10.1007/s10620-020-06476.
    PubMed     Abstract available


  82. SHARMA S, Weissman S, Mehta TI, Aziz M, et al
    Role of Hospital Teaching Status on Outcomes of Patients with Inflammatory Bowel Disease: A Nationwide Analysis.
    Dig Dis Sci. 2020 Jul 21. pii: 10.1007/s10620-020-06497.
    PubMed     Abstract available


  83. OLAIYA B, Renelus BD, Filon M, Saha S, et al
    Trends in Morbidity and Mortality Following Colectomy Among Patients with Ulcerative Colitis in the Biologic Era (2002-2013): A Study Using the National Inpatient Sample.
    Dig Dis Sci. 2020 Jul 16. pii: 10.1007/s10620-020-06474.
    PubMed     Abstract available


  84. ALGABA A, Guerra I, Ricart E, Iglesias E, et al
    Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06424.
    PubMed     Abstract available


  85. NADPARA N, Reichenbach ZW, Ehrlich AC, Friedenberg F, et al
    Current Status of Medical Therapy for Inflammatory Bowel Disease: The Wealth of Medications.
    Dig Dis Sci. 2020 Jul 13. pii: 10.1007/s10620-020-06471.
    PubMed     Abstract available


  86. GUPTA S, Aihara H, Trivedi HD, Srivastava A, et al
    Heading in the Right Dissection: Toward an Endoscopic Cancer Cure in a Patient with Long-Standing Ulcerative Colitis.
    Dig Dis Sci. 2020 Jul 13. pii: 10.1007/s10620-020-06465.
    PubMed    


  87. REGNER EH, Green AJ, Bain JL, Kattah MG, et al
    Importance of Not MSing Cerebral White Matter Disease in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jul 10. pii: 10.1007/s10620-020-06449.
    PubMed    


  88. KUMAR A, Teslova T, Taub E, Miller JD, et al
    Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications.
    Dig Dis Sci. 2020 Jul 2. pii: 10.1007/s10620-020-06439.
    PubMed     Abstract available


  89. BACH LE, Taleban S
    Vedolizumab (VDZ) for UC and CD: Still Safe and Effective After All These Years.
    Dig Dis Sci. 2020;65:1882-1884.
    PubMed    


  90. RIVIERE P, Laharie D
    Concise Commentary: Spaced Out-Reducing the Relapse Risk in IBD Patients by Lengthening Dosing Intervals of Anti-TNFs.
    Dig Dis Sci. 2020;65:2044-2045.
    PubMed    


  91. CRESPI M, Dulbecco P, De Ceglie A, Conio M, et al
    Strictures in Crohn's Disease: From Pathophysiology to Treatment.
    Dig Dis Sci. 2020;65:1904-1916.
    PubMed     Abstract available


  92. REINGLAS J, Gonczi L, Verdon C, Bessissow T, et al
    Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center.
    Dig Dis Sci. 2020;65:2046-2053.
    PubMed     Abstract available


  93. LI J, Liu L, Zhao Q, Chen M, et al
    Role of Interleukin-17 in Pathogenesis of Intestinal Fibrosis in Mice.
    Dig Dis Sci. 2020;65:1971-1979.
    PubMed     Abstract available


    June 2020
  94. STEIN DJ
    All Systems Go: Reconsidering Healthcare Costs in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jun 29. pii: 10.1007/s10620-020-06429.
    PubMed    


  95. FARBER ON, Weingarden A, Lee C, Braxton DR, et al
    Not in the Same Vein: Inflammatory Bowel Disease, Malignancy, and Enterocolic Lymphocytic Phlebitis.
    Dig Dis Sci. 2020 Jun 27. pii: 10.1007/s10620-020-06425.
    PubMed    


  96. BALRAM B, Lubov J, Theoret Y, Afif W, et al
    Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
    Dig Dis Sci. 2020 Jun 26. pii: 10.1007/s10620-020-06427.
    PubMed     Abstract available


  97. VISCIDO A, Latella G
    Non-medical Switching of Infliximab to CT-P13 Biosimilar in Inflammatory Bowel Disease: A Focus on the Definition of "Non-medical Switch".
    Dig Dis Sci. 2020 Jun 26. pii: 10.1007/s10620-020-06423.
    PubMed    


  98. DIBLEY L, Hart A, Duncan J, Knowles CH, et al
    Clinician Administered and Self-Report Survey Both Effective for Identifying Fecal Incontinence in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jun 20. pii: 10.1007/s10620-020-06418.
    PubMed     Abstract available


  99. TANDON P, Lee EY, Maxwell C, Hitz L, et al
    Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jun 12. pii: 10.1007/s10620-020-06381.
    PubMed     Abstract available


  100. DAI C, Jiang M
    Influence of Severe Vitamin D Deficiency on the Clinical Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jun 11. pii: 10.1007/s10620-020-06313.
    PubMed    


  101. GUTIN LS, Lam AY, Velayos FS, Santos SA, et al
    Going Viral: Management of IBD in the Era of the COVID-19 Pandemic.
    Dig Dis Sci. 2020;65:1571-1575.
    PubMed    


  102. GADHOK R, Gordon H, Sebepos-Rogers G, Baillie S, et al
    UK Patients of Bangladeshi Descent with Crohn's Disease Respond Less Well to TNF Antagonists Than Caucasian Patients.
    Dig Dis Sci. 2020;65:1790-1799.
    PubMed     Abstract available


  103. MCCURDY JD, Parlow S, Dawkins Y, Samji K, et al
    Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn's Disease.
    Dig Dis Sci. 2020;65:1784-1789.
    PubMed     Abstract available


    May 2020
  104. CUI Y, Zhang J, Chen Y, Chen LG, et al
    Upregulation of Fecal Epithelial Heparanase mRNA Is Associated with Increased Ulcerative Colitis Activity and Cancerization Risk.
    Dig Dis Sci. 2020 May 22. pii: 10.1007/s10620-020-06350.
    PubMed     Abstract available


  105. ZAIDI D, Wine E
    Building Fences: How A20 Protects the Intestinal Mucosa in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2020;65:1288-1290.
    PubMed    


  106. LATELLA G, Viscido A
    Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis.
    Dig Dis Sci. 2020;65:1299-1306.
    PubMed     Abstract available


  107. PAINCHART C, Brabant S, Duveau N, Nachury M, et al
    Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease.
    Dig Dis Sci. 2020;65:1445-1452.
    PubMed     Abstract available


    April 2020
  108. ROTTENSTREICH A, Shifman Z, Grisaru-Granovksy S, Mishael T, et al
    Factors Associated with Inflammatory Bowel Disease Flare During Pregnancy Among Women with Preconception Remission.
    Dig Dis Sci. 2020 Apr 30. pii: 10.1007/s10620-020-06282.
    PubMed     Abstract available


  109. BARBERIO B, Zingone F, Savarino EV
    Inflammatory Bowel Disease and Sleep Disturbance: As Usual, Quality Matters.
    Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06268.
    PubMed    


  110. COBURN ES, Siegel CA, Winter M, Shah ED, et al
    Hemophagocytic Lymphohistiocytosis Occurring in Inflammatory Bowel Disease: Systematic Review.
    Dig Dis Sci. 2020 Apr 16. pii: 10.1007/s10620-020-06252.
    PubMed     Abstract available


  111. WATANABE C, Nagahori M, Fujii T, Yokoyama K, et al
    Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes.
    Dig Dis Sci. 2020 Apr 6. pii: 10.1007/s10620-020-06221.
    PubMed     Abstract available


  112. VAN ERP LW, Roosenboom B, Komdeur P, Dijkstra-Heida W, et al
    Improvement of Fatigue and Quality of Life in Patients with Quiescent Inflammatory Bowel Disease Following a Personalized Exercise Program.
    Dig Dis Sci. 2020 Apr 1. pii: 10.1007/s10620-020-06222.
    PubMed     Abstract available


  113. CASTANO-RODRIGUEZ N, Paramsothy S, Kaakoush NO
    Promise of Fecal Microbiota Transplantation Therapy in Pouchitis.
    Dig Dis Sci. 2020;65:1107-1110.
    PubMed    


  114. OMORI T, Kambayashi H, Murasugi S, Ito A, et al
    Comparison of Lewis Score and Capsule Endoscopy Crohn's Disease Activity Index in Patients with Crohn's Disease.
    Dig Dis Sci. 2020;65:1180-1188.
    PubMed     Abstract available


  115. WU Y, Ghaly S, Kerr S, Jackson B, et al
    Level of UV Exposure, Skin Type, and Age Are More Important than Thiopurine Use for Keratinocyte Carcinoma Development in IBD Patients.
    Dig Dis Sci. 2020;65:1172-1179.
    PubMed     Abstract available


  116. SONG EM, Lee HS, Kim YJ, Oh EH, et al
    Incidence and Outcomes of Perianal Disease in an Asian Population with Crohn's Disease: A Nationwide Population-Based Study.
    Dig Dis Sci. 2020;65:1189-1196.
    PubMed     Abstract available


    March 2020
  117. LONGHI MS, Kokkotou E
    Lnc-ing RNA Expression with Disease Pathogenesis: MALAT1 and ANRIL in Ulcerative Colitis.
    Dig Dis Sci. 2020 Mar 30. pii: 10.1007/s10620-020-06216.
    PubMed    


  118. LEE JS, Lee HS, Jang BI, Kim ES, et al
    Low Bone Mineral Density in Young Patients Newly Diagnosed with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 28. pii: 10.1007/s10620-020-06220.
    PubMed     Abstract available


  119. HAM NS, Hwang SW, Oh EH, Kim J, et al
    Influence of Severe Vitamin D Deficiency on the Clinical Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 26. pii: 10.1007/s10620-020-06207.
    PubMed     Abstract available


  120. GUPTA A, Wash C, Wu Y, Sorrentino D, et al
    Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 23. pii: 10.1007/s10620-020-06205.
    PubMed     Abstract available


  121. FRIAS GOMES C, Narula N, Morao B, Nicola P, et al
    Mode of Delivery Does Not Affect the Risk of Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 21. pii: 10.1007/s10620-020-06204.
    PubMed     Abstract available


  122. XU M, Cen M, Shen Y, Zhu Y, et al
    Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
    Dig Dis Sci. 2020 Mar 20. pii: 10.1007/s10620-020-06208.
    PubMed     Abstract available


  123. CONLEY S, Jeon S, Lehner V, Proctor DD, et al
    Sleep Characteristics and Rest-Activity Rhythms Are Associated with Gastrointestinal Symptoms Among Adults with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 19. pii: 10.1007/s10620-020-06213.
    PubMed     Abstract available


  124. SYAL G, Robbins L, Kashani A, Bonthala N, et al
    Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2020 Mar 13. pii: 10.1007/s10620-020-06177.
    PubMed     Abstract available


  125. GU P, Yang E, Chittajallu P, McNeill C, et al
    Patient Perception and Clinical Impact of Direct-to-Consumer Advertising in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06180.
    PubMed     Abstract available


  126. JANSSON-KNODELL CL, Harris CE, Loftus EV Jr, Walker RC, et al
    Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06181.
    PubMed     Abstract available


  127. OKA A, Sartor RB
    Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
    Dig Dis Sci. 2020;65:757-788.
    PubMed     Abstract available


    February 2020
  128. KO MS, Rudrapatna VA, Avila P, Mahadevan U, et al
    Safety of Flexible Sigmoidoscopy in Pregnant Patients with Known or Suspected Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Feb 7. pii: 10.1007/s10620-020-06122.
    PubMed     Abstract available


  129. ZHU M, Xie J
    LncRNA MALAT1 Promotes Ulcerative Colitis by Upregulating lncRNA ANRIL.
    Dig Dis Sci. 2020 Feb 5. pii: 10.1007/s10620-020-06093.
    PubMed     Abstract available


  130. HO SSC, Keenan JI, Day AS
    The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases.
    Dig Dis Sci. 2020;65:376-390.
    PubMed     Abstract available


    January 2020
  131. LIMSRIVILAI J, Saleh ZM, Johnson LA, Stidham RW, et al
    Prevalence and Effect of Intestinal Infections Detected by a PCR-Based Stool Test in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 24. pii: 10.1007/s10620-020-06071.
    PubMed     Abstract available


  132. LAZARO CM, de Oliveira CC, Gambero A, Rocha T, et al
    Evaluation of Budesonide-Hydroxypropyl-beta-Cyclodextrin Inclusion Complex in Thermoreversible Gels for Ulcerative Colitis.
    Dig Dis Sci. 2020 Jan 23. pii: 10.1007/s10620-020-06075.
    PubMed     Abstract available


  133. BERNARD EJ, Fedorak RN, Jairath V
    Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 22. pii: 10.1007/s10620-019-06036.
    PubMed     Abstract available


  134. GIBSON DJ, Doherty GA
    Fast and Curious: An Algorithmic Approach to Infliximab Dosing in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2020 Jan 22. pii: 10.1007/s10620-020-06084.
    PubMed    


  135. BARRETT KE
    DRAwing Conclusions About the Basis of Diarrhea in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 16. pii: 10.1007/s10620-020-06060.
    PubMed    


  136. STATES V, O'Brien S, Rai JP, Roberts HL, et al
    Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Jan 10. pii: 10.1007/s10620-019-05999.
    PubMed     Abstract available


  137. SATYAM VR, Li PH, Reich J, Qazi T, et al
    Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 2. pii: 10.1007/s10620-019-06016.
    PubMed     Abstract available


  138. DUAN M, Cao L, Gao L, Gong J, et al
    Chyme Reinfusion Is Associated with Lower Rate of Postoperative Ileus in Crohn's Disease Patients After Stoma Closure.
    Dig Dis Sci. 2020;65:243-249.
    PubMed     Abstract available


  139. YANG Z, Bu C, Yuan W, Shen Z, et al
    Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn's Disease.
    Dig Dis Sci. 2020;65:150-157.
    PubMed     Abstract available


    December 2019
  140. TORRES P, Canete F, Nunez L, Aguilar A, et al
    Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?
    Dig Dis Sci. 2019 Dec 19. pii: 10.1007/s10620-019-06010.
    PubMed     Abstract available


  141. GUBATAN J, Triadafilopoulos G, Fernandez-Becker NQ
    Double Threat: Interplay of Celiac Disease with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Dec 11. pii: 10.1007/s10620-019-05994.
    PubMed    


  142. BILGRAMI Z, Abutaleb A, Chudy-Onwugaje K, Langenberg P, et al
    Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.
    Dig Dis Sci. 2019 Dec 2. pii: 10.1007/s10620-019-05953.
    PubMed     Abstract available


    November 2019
  143. SONNENBERG A, Turner KO, Genta RM
    Upper Gastrointestinal Disease Influences the Occurrence of Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Nov 27. pii: 10.1007/s10620-019-05972.
    PubMed     Abstract available


  144. GU P, Patel D, Lakhoo K, Ko J, et al
    Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis.
    Dig Dis Sci. 2019 Nov 21. pii: 10.1007/s10620-019-05967.
    PubMed     Abstract available


  145. BERTANI L, Bodini G, Mumolo MG, de Bortoli N, et al
    Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis.
    Dig Dis Sci. 2019 Nov 21. pii: 10.1007/s10620-019-05959.
    PubMed     Abstract available


  146. GOVANI SM, Berinstein JA, Waljee AK, Stidham RW, et al
    Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center.
    Dig Dis Sci. 2019 Nov 20. pii: 10.1007/s10620-019-05957.
    PubMed     Abstract available


  147. BOSSA F, Biscaglia G, Valvano MR, Costantino G, et al
    Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05904.
    PubMed     Abstract available


  148. KIM J, Feagins LA
    Managing Patients with Inflammatory Bowel Disease Who Develop Prostate Cancer.
    Dig Dis Sci. 2019 Nov 11. pii: 10.1007/s10620-019-05934.
    PubMed     Abstract available


  149. BOPARAI ES, Velayos FS, Roy A, Li C, et al
    Elevating the Technique: Resecting Complex Dysplastic Lesions of the Colon in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Nov 9. pii: 10.1007/s10620-019-05931.
    PubMed    


  150. PAI YC, Yu LC
    Is "Cholinergic" Stimulus Useful for Ulcerative Colitis Treatment?
    Dig Dis Sci. 2019 Nov 7. pii: 10.1007/s10620-019-05933.
    PubMed    


  151. LEVY AN, Ali N, Andrici J, Hamilton MJ, et al
    It's What's Up Front That Counts-Part Two: Esophageal Crohn's Disease Complicated by Recurrent Upper Gastrointestinal Bleeding.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05922.
    PubMed    


  152. JUNG YS, Han M, Park S, Cheon JH, et al
    Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
    Dig Dis Sci. 2019 Nov 1. pii: 10.1007/s10620-019-05867.
    PubMed     Abstract available


    October 2019
  153. BERRY SK, Takakura W, Bresee C, Melmed GY, et al
    Pain in Inflammatory Bowel Disease Is Not Improved During Hospitalization: The Impact of Opioids on Pain and Healthcare Utilization.
    Dig Dis Sci. 2019 Oct 25. pii: 10.1007/s10620-019-05906.
    PubMed     Abstract available


  154. SINGH SP, Chand HS, Banerjee S, Agarwal H, et al
    Acetylcholinesterase Inhibitor Pyridostigmine Bromide Attenuates Gut Pathology and Bacterial Dysbiosis in a Murine Model of Ulcerative Colitis.
    Dig Dis Sci. 2019 Oct 23. pii: 10.1007/s10620-019-05838.
    PubMed     Abstract available


    September 2019
  155. JANG J, Kwok B, Zhong H, Xia Y, et al
    Alvimopan for the Prevention of Postoperative Ileus in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2019 Sep 14. pii: 10.1007/s10620-019-05839.
    PubMed     Abstract available


  156. RIVIERE P, Laharie D, Marteau P
    Concise Commentary: Second Line Is Not Second Best-Continuing Validity of the Oxford Criteria in the Management of Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2019 Sep 5. pii: 10.1007/s10620-019-05788.
    PubMed    


  157. LIATSOS C, Papaefthymiou A, Tzouvala M, Doulberis M, et al
    Current Aspects on Differentiating Relapses from Over-Infections in Symptomatic Inflammatory Bowel Diseases.
    Dig Dis Sci. 2019;64:2686-2687.
    PubMed    


  158. PAREDES JM, Moreno N, Latorre P, Ripolles T, et al
    Clinical Impact of Sonographic Transmural Healing After Anti-TNF Antibody Treatment in Patients with Crohn's Disease.
    Dig Dis Sci. 2019;64:2600-2606.
    PubMed     Abstract available


    August 2019
  159. NAFTALI T
    Is Cannabis of Potential Value as a Therapeutic for Inflammatory Bowel Disease?
    Dig Dis Sci. 2019 Aug 6. pii: 10.1007/s10620-019-05763.
    PubMed    


  160. ABDALLA M, Norblad R, Olsson M, Landerholm K, et al
    Anorectal Function After Ileo-Rectal Anastomosis Is Better than Pelvic Pouch in Selected Ulcerative Colitis Patients.
    Dig Dis Sci. 2019 Aug 1. pii: 10.1007/s10620-019-05757.
    PubMed     Abstract available


  161. BURKE KE, Nayor J, Campbell EJ, Ananthakrishnan AN, et al
    Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence.
    Dig Dis Sci. 2019 Aug 1. pii: 10.1007/s10620-019-05754.
    PubMed     Abstract available


  162. WATANABE Y, Miyoshi N, Fujino S, Takahashi H, et al
    Cumulative Inflammation Could Be a Risk Factor for Intestinal Failure in Crohn's Disease.
    Dig Dis Sci. 2019;64:2280-2285.
    PubMed     Abstract available


    July 2019
  163. CHANG JY, Cheon JH
    Thiopurine Therapy in Patients With Inflammatory Bowel Disease: A Focus on Metabolism and Pharmacogenetics.
    Dig Dis Sci. 2019 Jul 9. pii: 10.1007/s10620-019-05720.
    PubMed     Abstract available


  164. WASZCZUK L, Waszczuk K, Waszczuk E
    CT in Crohn's Disease Is Beneficial for Patient Care and Should Not Be Feared.
    Dig Dis Sci. 2019;64:2056-2058.
    PubMed    


  165. CLARK-SNUSTAD KD, Singla A, Lee SD
    Efficacy of Infliximab in Crohn's Disease Patients with Prior Primary-Nonresponse to Tumor Necrosis Factor Antagonists.
    Dig Dis Sci. 2019;64:1952-1958.
    PubMed     Abstract available


  166. WEISSHOF R, Aharoni Golan M, Sossenheimer PH, El Jurdi K, et al
    Real-World Experience with Tofacitinib in IBD at a Tertiary Center.
    Dig Dis Sci. 2019;64:1945-1951.
    PubMed     Abstract available


  167. SCHAD CA, Haac BE, Cross RK, Syed A, et al
    Early Postoperative Anti-TNF Therapy Does Not Increase Complications Following Abdominal Surgery in Crohn's Disease.
    Dig Dis Sci. 2019;64:1959-1966.
    PubMed     Abstract available


    June 2019
  168. PAPAMICHAEL K, Cheifetz AS
    Integrin Calculus: The Predictive Power of Vedolizumab Concentrations in IBD Therapy.
    Dig Dis Sci. 2019;64:1397-1398.
    PubMed    


  169. ANNESE V
    Biosimilars in IBD: Similarity Breeds Contented Patients.
    Dig Dis Sci. 2019;64:1399-1400.
    PubMed    


  170. YARUR AJ, Bruss A, Naik S, Beniwal-Patel P, et al
    Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2019;64:1651-1659.
    PubMed     Abstract available


  171. MARTINEZ MJ, Ripolles T, Paredes JM, Moreno-Osset E, et al
    Intravenous Contrast-Enhanced Ultrasound for Assessing and Grading Postoperative Recurrence of Crohn's Disease.
    Dig Dis Sci. 2019;64:1640-1650.
    PubMed     Abstract available


  172. VASUDEVAN A, Raghunath A, Anthony S, Scanlon C, et al
    Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.
    Dig Dis Sci. 2019;64:1622-1631.
    PubMed     Abstract available


  173. PLEVRIS N, Jones GR, Jenkinson PW, Lyons M, et al
    Implementation of CT-P13 via a Managed Switch Programme in Crohn's Disease: 12-Month Real-World Outcomes.
    Dig Dis Sci. 2019;64:1660-1667.
    PubMed     Abstract available


    May 2019
  174. JIANG JX, Keat K, Swaminathan S
    ANCA-Associated Vasculitis in Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 May 15. pii: 10.1007/s10620-019-05654.
    PubMed    


  175. TSIAOUSSIS GI, Assimakopoulos SF, Thomopoulos KC
    The Writing Is on the Wall: The Utility of Mural Stratification for Risk Stratification of Hospitalized Patients with Severe Ulcerative Colitis.
    Dig Dis Sci. 2019 May 15. pii: 10.1007/s10620-019-05672.
    PubMed    


  176. MOORE AC, Bressler B
    Acute Severe Ulcerative Colitis: The Oxford Criteria No Longer Predict In-Hospital Colectomy Rates.
    Dig Dis Sci. 2019 May 15. pii: 10.1007/s10620-019-05668.
    PubMed     Abstract available


  177. LEY D, Hayney MS, Caldera F
    Third Time's a Charm: Immunization Strategies for Hepatitis B in Immunosuppressed Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 May 11. pii: 10.1007/s10620-019-05662.
    PubMed    


  178. ZHAO M, Burisch J
    Impact of Genes and the Environment on the Pathogenesis and Disease Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 May 9. pii: 10.1007/s10620-019-05648.
    PubMed     Abstract available


  179. SULTAN K, Shah D, Bhorania K, Zhou E, et al
    Increased Transfusion Requirements with Pharmacologic Thromboembolism Prophylaxis During Inflammatory Bowel Disease Exacerbation.
    Dig Dis Sci. 2019 May 7. pii: 10.1007/s10620-019-05650.
    PubMed     Abstract available


  180. NGUYEN VQ, Sorrentino D
    Diagnostic and Therapeutic Delays in the Management of Postoperative Crohn's Disease.
    Dig Dis Sci. 2019;64:1388-1389.
    PubMed    


  181. GHOSH S, Bressler B, Petkau J, Thakkar RB, et al
    Healthcare Providers Underestimate Patients' Glucocorticoid Use in Crohn's Disease.
    Dig Dis Sci. 2019;64:1142-1149.
    PubMed     Abstract available


    April 2019
  182. LEE H, Schneider Y, Lichtenstein GR
    Going Third Class: Treatment of Steroid-Dependent Ulcerative Colitis.
    Dig Dis Sci. 2019 Apr 24. pii: 10.1007/s10620-019-05610.
    PubMed    


  183. PRATT PK JR, Nunes D, Long MT, Farraye FA, et al
    Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Apr 3. pii: 10.1007/s10620-019-05595.
    PubMed     Abstract available


    March 2019
  184. DULAI PS, Osterman MT, Lasch K, Cao C, et al
    Market Access Analysis of Biologics and Small-Molecule Inhibitors for Inflammatory Bowel Disease Among US Health Insurance Policies.
    Dig Dis Sci. 2019 Mar 28. pii: 10.1007/s10620-019-05594.
    PubMed     Abstract available


  185. ADLER E, Tabaa A, Kassam Z, Zydek M, et al
    Capsule-Delivered Fecal Microbiota Transplant Is Safe and Well Tolerated in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2019 Mar 27. pii: 10.1007/s10620-019-05596.
    PubMed    


  186. QURESHI T, Peter Nguyen T, Wang R, Willis D, et al
    Improving Anemia in Inflammatory Bowel Disease: Impact of the Anemia Care Pathway.
    Dig Dis Sci. 2019 Mar 16. pii: 10.1007/s10620-019-05559.
    PubMed     Abstract available


  187. DAI C, Jiang M, Sun MJ
    High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2019 Mar 4. pii: 10.1007/s10620-019-05531.
    PubMed    


  188. GORDON N, Sebastian S
    Real-World Success of Biologic Therapy in IBD: No More Reasons to Be Anti Antibody.
    Dig Dis Sci. 2019;64:614-615.
    PubMed    


  189. SUAREZ FERRER C, Gonzalez-Lama Y, Gonzalez-Partida I, Calvo Moya M, et al
    Usefulness of Thiopurine Monotherapy for Crohn's Disease in the Era of Biologics: A Long-Term Single-Center Experience.
    Dig Dis Sci. 2019;64:875-879.
    PubMed     Abstract available


  190. CHECKLEY LA, Kristofek L, Kile S, Bolgar W, et al
    Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting.
    Dig Dis Sci. 2019;64:855-862.
    PubMed     Abstract available


    February 2019
  191. KOSLOWSKY B, Sadeh C, Grisaru-Granovsky S, Miskin H, et al
    Thiopurine Therapy for Inflammatory Bowel Disease During Pregnancy Is Not Associated with Anemia in the Infant.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-05555.
    PubMed     Abstract available


  192. COHEN-MEKELBURG S, Schneider Y, Gold S, Ghosh G, et al
    Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-05554.
    PubMed     Abstract available


  193. CUSHING KC, Kordbacheh H, Gee MS, Kambadakone A, et al
    CT-Visualized Colonic Mural Stratification Independently Predicts the Need for Medical or Surgical Rescue Therapy in Hospitalized Ulcerative Colitis Patients.
    Dig Dis Sci. 2019 Feb 22. pii: 10.1007/s10620-019-05520.
    PubMed     Abstract available


  194. LIU JJ, Rosson TB, Xie JJ, Harris ZP, et al
    Personalized Inflammatory Bowel Disease Care Reduced Hospitalizations.
    Dig Dis Sci. 2019 Feb 12. pii: 10.1007/s10620-019-05485.
    PubMed     Abstract available


  195. XU F, Dahlhamer JM, Terlizzi EP, Wheaton AG, et al
    Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015-2016.
    Dig Dis Sci. 2019 Feb 12. pii: 10.1007/s10620-019-05494.
    PubMed     Abstract available


  196. KIM DW, An JM, Hong SP, Hahm KB, et al
    Predictive Value of Procalcitonin in Acute Severe Ulcerative Colitis: Not Quite PerfeCT?
    Dig Dis Sci. 2019 Feb 7. pii: 10.1007/s10620-019-05481.
    PubMed    


  197. DEVA RAJOO G, Tan L, Lopez A, Lewindon P, et al
    Early Response to Corticosteroid and Baseline C-Reactive Protein Predicts Outcomes in Children with Moderate to Severe Ulcerative Colitis.
    Dig Dis Sci. 2019 Feb 7. pii: 10.1007/s10620-019-05486.
    PubMed     Abstract available


  198. PERERA LP, Radigan M, Guilday C, Banerjee I, et al
    Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-05488.
    PubMed     Abstract available


  199. MOSADEGHI S, Taleban S
    Alternate Settings for Infusions in Inflammatory Bowel Disease Patients: Homing in on Optimal Care.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-05480.
    PubMed    


  200. JACOBS JD, Wagner T, Gulotta G, Liao C, et al
    Impact of Angiotensin II Signaling Blockade on Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-5474.
    PubMed     Abstract available


  201. MENG Y, Li Y, Hao R, Li X, et al
    Analysis of Phenotypic Variables and Differentiation Between Untypical Crohn's Disease and Untypical Intestinal Tuberculosis.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-05491.
    PubMed     Abstract available


  202. ZHAO S, Wang J, Zhao Z
    Inflammatory Bowel Diseases and Sexual Health: More Studies Are Needed.
    Dig Dis Sci. 2019;64:594-595.
    PubMed    


  203. MITSIALIS V, Wu Y, Gewurz B, Bleday R, et al
    Raising the Barr: An Unexpected Lesion at Ileal-Cecal Resection.
    Dig Dis Sci. 2019;64:353-357.
    PubMed    


  204. IRWIN JR, Ferguson E, Simms LA, Hanigan K, et al
    Detectable Laboratory Abnormality Is Present up to 12 Months Prior to Diagnosis in Patients with Crohn's Disease.
    Dig Dis Sci. 2019;64:503-517.
    PubMed     Abstract available


  205. AHMAD W, Nguyen NH, Boland BS, Dulai PS, et al
    Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2019;64:382-390.
    PubMed     Abstract available


    January 2019
  206. AMORIM RF, Viegas ERC, Carneiro AJV, Esberard BC, et al
    Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5475.
    PubMed     Abstract available


  207. WU HM, Wei J, Li J, Wang K, et al
    Serum Procalcitonin as a Potential Early Predictor of Short-Term Outcomes in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2019 Jan 2. pii: 10.1007/s10620-018-5446.
    PubMed     Abstract available


  208. BILGRAMI Z, Abutaleb A, Chudy-Onwugaje K, Langenberg P, et al
    Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.
    Dig Dis Sci. 2019 Jan 2. pii: 10.1007/s10620-018-5433.
    PubMed     Abstract available


  209. IBORRA M, Herreras J, Bosca-Watts MM, Cortes X, et al
    Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse.
    Dig Dis Sci. 2019 Jan 2. pii: 10.1007/s10620-018-5429.
    PubMed     Abstract available


  210. NOCERINO A, Feathers A, Ivanina E, Durbin L, et al
    Mortality Risk of Inflammatory Bowel Disease: A Case-Control Study of New York State Death Records.
    Dig Dis Sci. 2019 Jan 2. pii: 10.1007/s10620-018-5430.
    PubMed     Abstract available


  211. FIELDS AC, Melnitchouk N
    Medical Prophylaxis of Post-Surgical Crohn's Disease Recurrence: Towards Timely Anti-TNF Therapy.
    Dig Dis Sci. 2019;64:7-8.
    PubMed    


  212. VELAYOS F
    Introduction to the IBD Case Conference Series.
    Dig Dis Sci. 2019;64:50-51.
    PubMed    


  213. PATIL SA, Flasar MH, Lin J, Lingohr-Smith M, et al
    Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn's Disease.
    Dig Dis Sci. 2019;64:60-67.
    PubMed     Abstract available


  214. ALTHOFF P, Schmiegel W, Lang G, Nicolas V, et al
    Creeping Fat Assessed by Small Bowel MRI Is Linked to Bowel Damage and Abdominal Surgery in Crohn's Disease.
    Dig Dis Sci. 2019;64:204-212.
    PubMed     Abstract available


  215. COHEN-MEKELBURG S, Gold S, Schneider Y, Dennis M, et al
    Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn's Disease Patients.
    Dig Dis Sci. 2019;64:196-203.
    PubMed     Abstract available


    December 2018
  216. SHRESTHA MP, Taleban S
    Obesity Is Associated with Increased Risk of Colectomy in Inflammatory Bowel Disease Patients Hospitalized with Clostridium difficile Infection.
    Dig Dis Sci. 2018 Dec 19. pii: 10.1007/s10620-018-5423.
    PubMed     Abstract available


  217. LEWIN SM, Wen KW, Velayos FS, Mahadevan U, et al
    How Dye May Prevent Dying from Cancer: Perceiving Imperceptible Dysplasia in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Dec 7. pii: 10.1007/s10620-018-5409.
    PubMed    


  218. HAKIM S, Ramireddy S, Amin M, Gebara S, et al
    Preoperative Misdiagnosis of Intestinal Behcet's Syndrome as Crohn's Disease Based on Superficial Colonoscopic Biopsies: Case Report and Systematic Review.
    Dig Dis Sci. 2018;63:3509-3515.
    PubMed    


  219. BIAN Y, Liu P, Zhong J, Hu Y, et al
    Quercetin Attenuates Adhesion Molecule Expression in Intestinal Microvascular Endothelial Cells by Modulating Multiple Pathways.
    Dig Dis Sci. 2018;63:3297-3304.
    PubMed     Abstract available


  220. GAO X, Li J, Chen M
    Effect of Homocysteine on the Differentiation of CD4(+) T Cells into Th17 Cells.
    Dig Dis Sci. 2018;63:3339-3347.
    PubMed     Abstract available


    November 2018
  221. BAJPAI M, Seril DN, Van Gurp J, Geng X, et al
    Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
    Dig Dis Sci. 2018 Nov 26. pii: 10.1007/s10620-018-5378.
    PubMed     Abstract available


  222. CHAO CY, Khoury AA, Aruljothy A, Restellini S, et al
    High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival.
    Dig Dis Sci. 2018 Nov 16. pii: 10.1007/s10620-018-5358.
    PubMed     Abstract available


  223. CHAPARRO M, Barreiro-de Acosta M, Echarri A, Almendros R, et al
    Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Nov 13. pii: 10.1007/s10620-018-5362.
    PubMed     Abstract available


    October 2018
  224. SARTINI A, Scaioli E, Liverani E, Bellanova M, et al
    Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy.
    Dig Dis Sci. 2018 Oct 17. pii: 10.1007/s10620-018-5329.
    PubMed     Abstract available


  225. MILLER M, Vu KN, Zemek A, Shelton A, et al
    TB or Not TB: Crohn's Disease, Peritoneal Tuberculosis, or Both?
    Dig Dis Sci. 2018 Oct 17. pii: 10.1007/s10620-018-5334.
    PubMed    


  226. CALDERA F, Misch EA, Saha S, Wald A, et al
    Immunosuppression Does Not Affect Antibody Concentrations to Measles, Mumps, and Rubella in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Oct 13. pii: 10.1007/s10620-018-5321.
    PubMed     Abstract available


  227. MA C, Ascoytia C, McCarrier KP, Martin M, et al
    Physicians' Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn's Disease.
    Dig Dis Sci. 2018;63:2555-2563.
    PubMed     Abstract available


  228. NASSER Y, Labetoulle R, Harzallah I, Berger AE, et al
    Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD.
    Dig Dis Sci. 2018;63:2714-2721.
    PubMed     Abstract available


  229. KEDIA S, Jain S, Goyal S, Bopanna S, et al
    Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe Disease.
    Dig Dis Sci. 2018;63:2747-2753.
    PubMed     Abstract available


  230. PATIL SA, Cross RK
    More Skin in the Game: Screening for Skin Cancer in IBD Patients.
    Dig Dis Sci. 2018;63:2497-2499.
    PubMed    


  231. LEE D, Swan CK, Suskind D, Wahbeh G, et al
    Children with Crohn's Disease Frequently Consume Select Food Additives.
    Dig Dis Sci. 2018;63:2722-2728.
    PubMed     Abstract available


    September 2018
  232. CHIOCCHETTI A, Prodam F, Dianzani U
    Homocysteine and Folate in Inflammatory Bowel Disease: Can Reducing Sulfur Reduce Suffering?
    Dig Dis Sci. 2018 Sep 6. pii: 10.1007/s10620-018-5274.
    PubMed    


  233. SCHIFF ER, Frampton M, Semplici F, Bloom SL, et al
    A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population.
    Dig Dis Sci. 2018 Sep 3. pii: 10.1007/s10620-018-5219.
    PubMed     Abstract available


  234. FIORUCCI S, Biagioli M, Distrutti E
    Immunephenotype Predicts Response to Vedolizumab: Integrating Clinical and Biochemical Biomarkers in the Treatment of Inflammatory Bowel Diseases.
    Dig Dis Sci. 2018;63:2168-2171.
    PubMed    


  235. KIM ES, Kim SK, Jang BI, Kim KO, et al
    Disease Activity Patterns Recorded Using a Mobile Monitoring System Are Associated with Clinical Outcomes of Patients with Crohn's Disease.
    Dig Dis Sci. 2018;63:2220-2230.
    PubMed     Abstract available


    August 2018
  236. SHIN DS, Cheon JH, Park YE, Park Y, et al
    Extensive Disease Subtypes in Adult Patients with Ulcerative Colitis: Non-pancolitis Versus Pancolitis.
    Dig Dis Sci. 2018 Aug 25. pii: 10.1007/s10620-018-5218.
    PubMed     Abstract available


  237. MICIC D, Yarur A, Gonsalves A, Rao VL, et al
    Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
    Dig Dis Sci. 2018 Aug 22. pii: 10.1007/s10620-018-5249.
    PubMed     Abstract available


  238. LI Y, Xu H, Xu T, Xiao M, et al
    Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
    Dig Dis Sci. 2018 Aug 9. pii: 10.1007/s10620-018-5230.
    PubMed     Abstract available


    July 2018
  239. CHABLANI SV, Ramos-Rivers C, Binion DG, Szigethy E, et al
    Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance and Healthcare Utilization in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 19. pii: 10.1007/s10620-018-5194.
    PubMed    


  240. BAR-GIL SHITRIT A, Chen-Shuali C, Adar T, Koslowsky B, et al
    Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 19. pii: 10.1007/s10620-018-5207.
    PubMed     Abstract available


  241. JUNCADELLA A, Papamichael K, Vaughn BP, Cheifetz AS, et al
    Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 13. pii: 10.1007/s10620-018-5202.
    PubMed     Abstract available


  242. CHANG JY, Cheon JH, Park Y, Park SJ, et al
    Does Medical Acceleration Improve Outcomes in Ulcerative Colitis Patients Who Are in Clinical Remission but Have Endoscopic Inflammation?
    Dig Dis Sci. 2018 Jul 9. pii: 10.1007/s10620-018-5193.
    PubMed     Abstract available


  243. SITKIN S, Pokrotnieks J
    Alterations in Polyunsaturated Fatty Acid Metabolism and Reduced Serum Eicosadienoic Acid Level in Ulcerative Colitis: Is There a Place for Metabolomic Fatty Acid Biomarkers in IBD?
    Dig Dis Sci. 2018 Jul 9. pii: 10.1007/s10620-018-5182.
    PubMed    


  244. DAMAS OM, Estes D, Avalos D, Quintero MA, et al
    Hispanics Coming to the US Adopt US Cultural Behaviors and Eat Less Healthy: Implications for Development of Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 7. pii: 10.1007/s10620-018-5185.
    PubMed     Abstract available


  245. AL-TAWEEL T, Strohl M, Pai M, Martel M, et al
    A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 3. pii: 10.1007/s10620-018-5178.
    PubMed     Abstract available


  246. LING C, Gavin M, Hanson J, McCarthy DM, et al
    Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn's Disease: Don't DILI Dally.
    Dig Dis Sci. 2018;63:1751-1755.
    PubMed    


  247. LIAN L, Huang Q, Zhang L, Qin H, et al
    Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease.
    Dig Dis Sci. 2018;63:1821-1834.
    PubMed     Abstract available


    June 2018
  248. ZHU H, Huang S, Yue M, Chen W, et al
    Dysregulated Up-Frameshift Protein 1 Promotes Ulcerative Colitis Pathogenesis Through the TNFR1-NF-kappaB/MAPKs Pathway.
    Dig Dis Sci. 2018 Jun 29. pii: 10.1007/s10620-018-5171.
    PubMed     Abstract available


  249. VEDAMURTHY A, Xu L, Luther J, Colizzo F, et al
    Long-Term Outcomes of Immunosuppression-Naive Steroid Responders Following Hospitalization for Ulcerative Colitis.
    Dig Dis Sci. 2018 Jun 27. pii: 10.1007/s10620-018-5176.
    PubMed     Abstract available


  250. ANDERSON AJM, Ferris LK, Binion DG, Smith KJ, et al
    Cost-Effectiveness of Melanoma Screening in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jun 13. pii: 10.1007/s10620-018-5141.
    PubMed     Abstract available


  251. WANG P, Hu J, Ghadermarzi S, Raza A, et al
    Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA.
    Dig Dis Sci. 2018 Jun 4. pii: 10.1007/s10620-018-5142.
    PubMed     Abstract available


  252. ARORA U, Kedia S, Garg P, Bopanna S, et al
    Colonic Crohn's Disease Is Associated with Less Aggressive Disease Course Than Ileal or Ileocolonic Disease.
    Dig Dis Sci. 2018;63:1592-1599.
    PubMed     Abstract available


  253. ELURI S, Cross RK, Martin C, Weinfurt KP, et al
    Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex Life.
    Dig Dis Sci. 2018;63:1572-1582.
    PubMed     Abstract available


  254. KOK B, Lester ELW, Lee WM, Hanje AJ, et al
    Acute Liver Failure from Tumor Necrosis Factor-alpha Antagonists: Report of Four Cases and Literature Review.
    Dig Dis Sci. 2018;63:1654-1666.
    PubMed     Abstract available


    May 2018
  255. ABRAHAM BP, Quigley EMM
    A Probiotic for Ulcerative Colitis: The Culture Wars Continue.
    Dig Dis Sci. 2018 May 21. pii: 10.1007/s10620-018-5097.
    PubMed    


  256. CHANDRADAS S, Khalili H, Ananthakrishnan A, Wayman C, et al
    Does Obesity Influence the Risk of Clostridium difficile Infection Among Patients with Ulcerative Colitis?
    Dig Dis Sci. 2018 May 19. pii: 10.1007/s10620-018-5108.
    PubMed     Abstract available


  257. COHEN-MEKELBURG S, Tafesh Z, Coburn E, Weg R, et al
    Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 May 14. pii: 10.1007/s10620-018-5109.
    PubMed     Abstract available


  258. WEIZMAN AV, Sharma R, Afzal NM, Xu W, et al
    Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 May 8. pii: 10.1007/s10620-018-5096.
    PubMed     Abstract available


  259. UZZAN M
    Concise Commentary: Calling in Your Marker-Rectal CD30-Positive Cells Differentiate Ulcerative Colitis from Crohn's Disease.
    Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5099.
    PubMed    


  260. CHETCUTI ZAMMIT S, McAlindon ME, Hale MF, Sidhu R, et al
    Isolated Terminal Ileitis: When Is It Not Crohn's Disease?
    Dig Dis Sci. 2018;63:1367.
    PubMed    


  261. MOGILEVSKI T, Sparrow MP
    Infliximab Versus Adalimumab in Patients with Biologic-Naive Crohn's Disease: Is the Difference Real?
    Dig Dis Sci. 2018;63:1094-1096.
    PubMed    


  262. BENMASSAOUD A, Al-Taweel T, Sasson MS, Moza D, et al
    Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naive Crohn's Disease.
    Dig Dis Sci. 2018;63:1302-1310.
    PubMed     Abstract available


    April 2018
  263. ANDERSON A, Ferris LK, Click B, Ramos-Rivers C, et al
    Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Apr 30. pii: 10.1007/s10620-018-5056.
    PubMed     Abstract available


  264. PERERA LP, Bhandari S, Liu R, Guilday C, et al
    Advanced Age Does Not Negatively Impact Health-Related Quality of Life in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Apr 30. pii: 10.1007/s10620-018-5076.
    PubMed     Abstract available


  265. BAR-GIL SHITRIT A, Cohen Y, Hassin O, Ben Ya'acov A, et al
    Correction to: Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our 'IBD MOM' Clinic.
    Dig Dis Sci. 2018 Apr 27. pii: 10.1007/s10620-018-5084.
    PubMed     Abstract available


  266. SHAH R, Ho EY, Kramer JR, Richardson P, et al
    Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists.
    Dig Dis Sci. 2018 Apr 16. pii: 10.1007/s10620-018-5042.
    PubMed     Abstract available


  267. LIMSRIVILAI J, Rao K, Stidham RW, Govani SM, et al
    Systemic Inflammatory Responses in Ulcerative Colitis Patients and Clostridium difficile Infection.
    Dig Dis Sci. 2018 Apr 12. pii: 10.1007/s10620-018-5044.
    PubMed     Abstract available


  268. SHITRIT AB, Cohen Y, Hassin O, Ya'acov AB, et al
    Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our 'IBD MOM' Clinic.
    Dig Dis Sci. 2018 Apr 6. pii: 10.1007/s10620-018-5048.
    PubMed     Abstract available


  269. CAVOUNIDIS A, Uhlig HH
    Crohn's Disease in Niemann-Pick Disease Type C1: Caught in the Cross-Fire of Host-Microbial Interactions.
    Dig Dis Sci. 2018;63:811-813.
    PubMed    


  270. LING J, Buurman D, Ravikumara M, Mews C, et al
    Accelerated Step-Up Infliximab Use Is Associated with Sustained Primary Response in Pediatric Crohn's Disease.
    Dig Dis Sci. 2018;63:1003-1010.
    PubMed     Abstract available


  271. CICCONE F, Ciccone A, Di Ruscio M, Vernia F, et al
    IgG4-Related Disease Mimicking Crohn's Disease: A Case Report and Review of Literature.
    Dig Dis Sci. 2018;63:1072-1086.
    PubMed    


  272. NOBEL YR, Axelrad J, Lewis SK, Whittier S, et al
    Stool PCR for Gastrointestinal Pathogens in Patients With and Without Immune-Mediated Intestinal Diseases.
    Dig Dis Sci. 2018;63:996-1002.
    PubMed     Abstract available


  273. COUGNOUX A, Movassaghi M, Picache JA, Iben JR, et al
    Gastrointestinal Tract Pathology in a BALB/c Niemann-Pick Disease Type C1 Null Mouse Model.
    Dig Dis Sci. 2018;63:870-880.
    PubMed     Abstract available


    March 2018
  274. AVALOS DJ, Mendoza-Ladd A, Zuckerman MJ, Bashashati M, et al
    Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5022.
    PubMed     Abstract available


  275. CALDERA F, Saha S, Wald A, Garmoe CA, et al
    Lower Sustained Diphtheria and Pertussis Antibody Concentrations in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5043.
    PubMed     Abstract available


  276. KERLIN AM, Long M, Kappelman M, Martin C, et al
    Profiles of Patients Who Use Marijuana for Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5040.
    PubMed     Abstract available


  277. HOLMSTROM RB, Mogensen DV, Brynskov J, Ainsworth MA, et al
    Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Mar 21. pii: 10.1007/s10620-018-5020.
    PubMed     Abstract available


  278. BERRY N, Sinha SK, Bhattacharya A, Prasad KK, et al
    Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.
    Dig Dis Sci. 2018 Mar 21. pii: 10.1007/s10620-018-5026.
    PubMed     Abstract available


  279. NISHIUMI S, Izumi Y, Yoshida M
    Alterations in Docosahexaenoic Acid-Related Lipid Cascades in Inflammatory Bowel Disease Model Mice.
    Dig Dis Sci. 2018 Mar 21. pii: 10.1007/s10620-018-5025.
    PubMed     Abstract available


  280. FABIAN O, Hradsky O, Drskova T, Mikus F, et al
    Immunohistochemical Assessment of CD30+ Lymphocytes in the Intestinal Mucosa Facilitates Diagnosis of Pediatric Ulcerative Colitis.
    Dig Dis Sci. 2018 Mar 14. pii: 10.1007/s10620-018-5018.
    PubMed     Abstract available


  281. KUSAKA J, Shiga H, Kuroha M, Kimura T, et al
    Residual Lesions on Capsule Endoscopy Is Associated with Postoperative Clinical Recurrence in Patients with Crohn's Disease.
    Dig Dis Sci. 2018;63:768-774.
    PubMed     Abstract available


  282. LUTHER J, Gala M, Patel SJ, Dave M, et al
    Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways.
    Dig Dis Sci. 2018;63:738-745.
    PubMed     Abstract available


    February 2018
  283. FLEISHER M, Marsal J, Lee SD, Frado LE, et al
    Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Feb 26. pii: 10.1007/s10620-018-4971.
    PubMed     Abstract available


  284. MAK WY, Buisson A, Andersen MJ Jr, Lei D, et al
    Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2018 Feb 22. pii: 10.1007/s10620-018-4980.
    PubMed     Abstract available


  285. KIELY CJ, Clark A, Bhattacharyya J, Moran GW, et al
    Acetarsol Suppositories: Effective Treatment for Refractory Proctitis in a Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Feb 19. pii: 10.1007/s10620-017-4890.
    PubMed     Abstract available


  286. MATSUOKA K, Uemura Y, Kanai T, Kunisaki R, et al
    Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis.
    Dig Dis Sci. 2018 Feb 15. pii: 10.1007/s10620-018-4946.
    PubMed     Abstract available


  287. MICIC D, Yarur A, Gonsalves A, Rao VL, et al
    Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
    Dig Dis Sci. 2018 Feb 8. pii: 10.1007/s10620-018-4941.
    PubMed     Abstract available


    January 2018
  288. FERNANDEZ-BLANCO JI, Fernandez-Diaz G, Cara C, Vera MI, et al
    Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.
    Dig Dis Sci. 2018 Jan 25. pii: 10.1007/s10620-018-4935.
    PubMed     Abstract available


  289. BODEN EK, Shows DM, Chiorean MV, Lord JD, et al
    Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 25. pii: 10.1007/s10620-018-4924.
    PubMed     Abstract available


  290. LUKACH AJ, Saul MI, Ferris LK, Swoger JM, et al
    Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 22. pii: 10.1007/s10620-018-4919.
    PubMed     Abstract available


  291. FEUERSTEIN JD, Curran T, Alosilla M, Cataldo T, et al
    Mortality Is Rare Following Elective and Non-elective Surgery for Ulcerative Colitis, but Mild Postoperative Complications Are Common.
    Dig Dis Sci. 2018 Jan 20. pii: 10.1007/s10620-018-4922.
    PubMed     Abstract available


  292. ANDRADE P, Lopes S, Gaspar R, Nunes A, et al
    Anti-Tumor Necrosis Factor-alpha-Induced Dermatological Complications in a Large Cohort of Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Jan 18. pii: 10.1007/s10620-018-4921.
    PubMed     Abstract available


  293. PAPAMICHAEL K, Vajravelu RK, Osterman MT, Cheifetz AS, et al
    Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 16. pii: 10.1007/s10620-018-4917.
    PubMed     Abstract available


  294. OSAMURA A, Suzuki Y
    Fourteen-Year Anti-TNF Therapy in Crohn's Disease Patients: Clinical Characteristics and Predictive Factors.
    Dig Dis Sci. 2018;63:204-208.
    PubMed     Abstract available


  295. NGUYEN VQ, Mays JL, Lang M, Wu Y, et al
    Knowledge Gaps in the Management of Postoperative Crohn's Disease: A US National Survey.
    Dig Dis Sci. 2018;63:53-60.
    PubMed     Abstract available


    December 2017
  296. SHAMAH S, Schneider J, Korelitz BI
    High Incidence of Recurrent Crohn's Disease Following Colectomy for Ulcerative Colitis Revealed with Long Follow-Up.
    Dig Dis Sci. 2017 Dec 28. pii: 10.1007/s10620-017-4873.
    PubMed     Abstract available


  297. GIUFFRIDA P, Corazza GR, Di Sabatino A
    Old and New Lymphocyte Players in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Dec 23. pii: 10.1007/s10620-017-4892.
    PubMed     Abstract available


    November 2017
  298. FEUERSTEIN JD, Papamichael K, Popejoy S, Nadelson A, et al
    Targeted Physician Education and Standardizing Documentation Improves Documented Reporting with Inflammatory Bowel Disease Quality Measures in a Large Academic and Private Practice.
    Dig Dis Sci. 2017 Nov 17. doi: 10.1007/s10620-017-4845.
    PubMed     Abstract available


  299. GURVITS GE
    Lax Prophylaxis: Vaccinating the Inflammatory Bowel Disease Patient.
    Dig Dis Sci. 2017 Nov 10. doi: 10.1007/s10620-017-4836.
    PubMed    


  300. FISCHER M, Campbell SC, Calley CSJ, Helper DJ, et al
    Risk Factors for Rescue Therapy in Crohn's Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-Up.
    Dig Dis Sci. 2017;62:3131-3137.
    PubMed     Abstract available


  301. HAR-NOY O, Katz L, Avni T, Battat R, et al
    Chromoendoscopy, Narrow-Band Imaging or White Light Endoscopy for Neoplasia Detection in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2017;62:2982-2990.
    PubMed     Abstract available


    October 2017
  302. MORSHEDZADEH N, Rahimlou M, Asadzadeh Aghdaei H, Shahrokh S, et al
    Association Between Adipokines Levels with Inflammatory Bowel Disease (IBD): Systematic Reviews.
    Dig Dis Sci. 2017 Oct 30. doi: 10.1007/s10620-017-4806.
    PubMed     Abstract available


  303. TSE CS, Deepak P, Smyrk TC, Raffals LE, et al
    Isolated Acute Terminal Ileitis Without Preexisting Inflammatory Bowel Disease Rarely Progresses to Crohn's Disease.
    Dig Dis Sci. 2017 Oct 24. doi: 10.1007/s10620-017-4803.
    PubMed     Abstract available


  304. FINE S, Nee J, Thakuria P, Duff B, et al
    Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 24. doi: 10.1007/s10620-017-4781.
    PubMed     Abstract available


  305. CAMPBELL JP, Burton E, Wymer S, Shaw M, et al
    Out-of-Pocket Cost Is a Barrier to Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 20. doi: 10.1007/s10620-017-4808.
    PubMed     Abstract available


  306. CALLOWAY A, Dalal R, Beaulieu DB, Duley C, et al
    Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 20. doi: 10.1007/s10620-017-4800.
    PubMed     Abstract available


  307. DAI C, Jiang M, Sun MJ
    Fecal Calprotectin in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 17. doi: 10.1007/s10620-017-4799.
    PubMed    


  308. LINARES PM, Algaba A, Urzainqui A, Guijarro-Rojas M, et al
    Ratio of Circulating Estrogen Receptors Beta and Alpha (ERbeta/ERalpha) Indicates Endoscopic Activity in Patients with Crohn's Disease.
    Dig Dis Sci. 2017;62:2744-2754.
    PubMed     Abstract available


  309. SEO H, Ye BD, Song EM, Lee SH, et al
    Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn's Disease: A Hospital-Based Cohort Study from Korea.
    Dig Dis Sci. 2017;62:2882-2893.
    PubMed     Abstract available


  310. LI J, Yan Y, Meng Z, Liu S, et al
    Microscopic Colitis Evolved Into Inflammatory Bowel Diseases Is Characterized by Increased Th1/Tc1 Cells in Colonic Mucosal Lamina Propria.
    Dig Dis Sci. 2017;62:2755-2767.
    PubMed     Abstract available


    September 2017
  311. PUOLANNE AM, Kolho KL, Alfthan H, Ristimaki A, et al
    Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4770.
    PubMed     Abstract available


  312. HUSSEY M, Holleran G, Smith S, Sherlock M, et al
    The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Sep 20. doi: 10.1007/s10620-017-4753.
    PubMed     Abstract available


  313. HAAS L, Chevalier R, Major BT, Enders F, et al
    Biologic Agents Are Associated with Excessive Weight Gain in Children with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Sep 11. doi: 10.1007/s10620-017-4745.
    PubMed     Abstract available


  314. KUMAR V, Shah Y, Patel D, Khan N, et al
    Elderly-Onset and Adult-Onset Ulcerative Colitis Are More Similar than Previously Reported in a Nationwide Cohort.
    Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4734.
    PubMed     Abstract available


  315. DE BARROS KSC, Flores C, Harlacher L, Francesconi CFM, et al
    Evolution of Clinical Behavior in Crohn's Disease: Factors Associated with Complicated Disease and Surgery.
    Dig Dis Sci. 2017;62:2481-2488.
    PubMed     Abstract available


  316. BELLOLIO ROTH F, Gomez J, Cerda J
    Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012.
    Dig Dis Sci. 2017;62:2311-2317.
    PubMed     Abstract available


  317. SHAH A, Talley NJ, Walker M, Koloski N, et al
    Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?
    Dig Dis Sci. 2017;62:2472-2480.
    PubMed     Abstract available


    August 2017
  318. CASTANEDA G, Liu B, Torres S, Bhuket T, et al
    Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.
    Dig Dis Sci. 2017 Aug 30. doi: 10.1007/s10620-017-4733.
    PubMed     Abstract available


  319. POURAFKARI L, Masnadi-Shirazi K, Taban M, Mohammadi S, et al
    Higher Frequency of Nocturnal Blood Pressure Dipping but Not Heart Rate Dipping in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Aug 23. doi: 10.1007/s10620-017-4712.
    PubMed     Abstract available


  320. PHAM HV, Hasan I, Udaltsova N, Pham K, et al
    Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents.
    Dig Dis Sci. 2017 Aug 23. doi: 10.1007/s10620-017-4716.
    PubMed     Abstract available


  321. ZIZZO MG, Serio R
    Therapeutic Potential of the Gabaergic System in Ulcerative Colitis: Current Status and Perspectives.
    Dig Dis Sci. 2017 Aug 5. doi: 10.1007/s10620-017-4709.
    PubMed    


  322. CARRASCO A, Fernandez-Banares F
    Th1 Pathway: The Missing Link Between Inflammatory Bowel Disease and Microscopic Colitis?
    Dig Dis Sci. 2017 Aug 3. doi: 10.1007/s10620-017-4692.
    PubMed    


  323. ALLOCCA M, Fiorino G, Danese S
    Biosimilar Drugs for Inflammatory Bowel Disease: Is Similar Good Enough?
    Dig Dis Sci. 2017 Aug 3. doi: 10.1007/s10620-017-4693.
    PubMed    


  324. KAMAT N, Ganesh Pai C, Surulivel Rajan M, Kamath A, et al
    Cost of Illness in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Aug 1. doi: 10.1007/s10620-017-4690.
    PubMed     Abstract available


  325. BAFFORD AC, Latushko A, Hansraj N, Jambaulikar G, et al
    The Use of Temporary Fecal Diversion in Colonic and Perianal Crohn's Disease Does Not Improve Outcomes.
    Dig Dis Sci. 2017;62:2079-2086.
    PubMed     Abstract available


  326. JEWEL SAMADDER N, Valentine JF, Guthery S, Singh H, et al
    Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.
    Dig Dis Sci. 2017;62:2126-2132.
    PubMed     Abstract available


    July 2017
  327. MOURAD FH, Yau Y, Wasinger VC, Leong RW, et al
    Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.
    Dig Dis Sci. 2017 Jul 17. doi: 10.1007/s10620-017-4673.
    PubMed     Abstract available


  328. SARTINI A, Gitto S, Villa E
    Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?
    Dig Dis Sci. 2017 Jul 4. doi: 10.1007/s10620-017-4665.
    PubMed    


    June 2017
  329. AGGARWAL S, Ahuja V, Paul J
    Attenuated GABAergic Signaling in Intestinal Epithelium Contributes to Pathogenesis of Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 30. doi: 10.1007/s10620-017-4662.
    PubMed     Abstract available


  330. SMITS LJT, Grelack A, Derikx LAAP, de Jong DJ, et al
    Long-Term Clinical Outcomes After Switching from Remicade(R) to Biosimilar CT-P13 in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 30. doi: 10.1007/s10620-017-4661.
    PubMed     Abstract available


  331. ARGUELLES-ARIAS F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, et al
    Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
    Dig Dis Sci. 2017 Jun 28. doi: 10.1007/s10620-017-4657.
    PubMed    


  332. KIM ES, Kim KO, Jang BI, Kim EY, et al
    Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 21. doi: 10.1007/s10620-017-4634.
    PubMed     Abstract available


  333. ELURI S, Parian AM, Limketkai BN, Ha CY, et al
    Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 19. doi: 10.1007/s10620-017-4652.
    PubMed     Abstract available


  334. LIU L, Li X
    NLRP3 Inflammasome in Inflammatory Bowel Disease: Friend or Foe?
    Dig Dis Sci. 2017 Jun 19. doi: 10.1007/s10620-017-4650.
    PubMed    


  335. JUNG YS, Han M, Kim WH, Park S, et al
    Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
    Dig Dis Sci. 2017 Jun 7. doi: 10.1007/s10620-017-4640.
    PubMed     Abstract available


  336. FRIEDMAN S
    Gestational Weight Gain: A New Factor Influencing Pregnancy Outcomes in Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 2. doi: 10.1007/s10620-017-4635.
    PubMed    


  337. LI J, Ueno A, Iacucci M, Fort Gasia M, et al
    Crossover Subsets of CD4+ T Lymphocytes in the Intestinal Lamina Propria of Patients with Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 1. doi: 10.1007/s10620-017-4596.
    PubMed     Abstract available


  338. CAMPOS C, Perrey A, Lambert C, Pereira B, et al
    Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
    Dig Dis Sci. 2017;62:1628-1636.
    PubMed     Abstract available


  339. OBI K, Hinton A, Sobotka L, Levine E, et al
    Hospital-Acquired Conditions Are Associated with Worse Outcomes in Crohn's Disease-Related Hospitalizations.
    Dig Dis Sci. 2017;62:1621-1627.
    PubMed     Abstract available


  340. NAFTALI T, Mechulam R, Marii A, Gabay G, et al
    Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.
    Dig Dis Sci. 2017;62:1615-1620.
    PubMed     Abstract available


  341. KIM JW, Lee HS, Ye BD, Yang SK, et al
    Incidence of and Risk Factors for Free Bowel Perforation in Patients with Crohn's Disease.
    Dig Dis Sci. 2017;62:1607-1614.
    PubMed     Abstract available


  342. FUMERY M, Kohut M, Gower-Rousseau C, Duhamel A, et al
    Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based Study.
    Dig Dis Sci. 2017;62:1571-1579.
    PubMed     Abstract available


    May 2017
  343. MILLER TL, Lee D, Giefer M, Wahbeh G, et al
    Nutritional Therapy in Very Early-Onset Inflammatory Bowel Disease: A Case Report.
    Dig Dis Sci. 2017 May 27. doi: 10.1007/s10620-017-4616.
    PubMed     Abstract available


  344. TASSON L, Canova C, Vettorato MG, Savarino E, et al
    Influence of Diet on the Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 May 26. doi: 10.1007/s10620-017-4620.
    PubMed     Abstract available


  345. RINAWI F, Assa A, Bashir H, Peleg S, et al
    Clinical and Phenotypic Differences in Inflammatory Bowel Disease Among Arab and Jewish Children in Israel.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4623.
    PubMed     Abstract available


  346. ZULLOW S, Jambaulikar G, Rustgi A, Quezada S, et al
    Risk Factors for Vitamin D Deficiency and Impact of Repletion in a Tertiary Care Inflammatory Bowel Disease Population.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4614.
    PubMed     Abstract available


  347. LAZARIDIS LD, Pistiki A, Giamarellos-Bourboulis EJ, Georgitsi M, et al
    Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4609.
    PubMed     Abstract available


    April 2017
  348. MEIGHANI A, Hart BR, Bourgi K, Miller N, et al
    Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 27. doi: 10.1007/s10620-017-4580.
    PubMed     Abstract available


  349. SAEZ-GONZALEZ E, Moret I, Alvarez-Sotomayor D, Diaz-Jaime FC, et al
    Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 21. doi: 10.1007/s10620-017-4577.
    PubMed     Abstract available


  350. JIANG Y, Lin O, Sinha SR
    Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure.
    Dig Dis Sci. 2017 Apr 17. doi: 10.1007/s10620-017-4574.
    PubMed     Abstract available


  351. PIECHOTA-POLANCZYK A, Wlodarczyk M, Sobolewska-Wlodarczyk A, Jonakowski M, et al
    Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
    Dig Dis Sci. 2017 Apr 8. doi: 10.1007/s10620-017-4568.
    PubMed     Abstract available


  352. CAO B, Zhou X, Ma J, Zhou W, et al
    Role of MiRNAs in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 8. doi: 10.1007/s10620-017-4567.
    PubMed     Abstract available


  353. BARTELS LE, Dahlerup JF
    Association of Helicobacter pylori and Crohn's Disease Incidence: An Inversion Reaction?
    Dig Dis Sci. 2017 Apr 5. doi: 10.1007/s10620-017-4561.
    PubMed    


  354. ULLMAN TA, Itzkowitz SH
    Prognosis of Colorectal Cancer in Inflammatory Bowel Disease: Data from a State Registry.
    Dig Dis Sci. 2017 Apr 3. doi: 10.1007/s10620-017-4557.
    PubMed    


  355. HIRTEN R, Sands BE, Cohen BL
    The Whys and Hows of Fourth-Year Inflammatory Bowel Disease Fellowships.
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4555.
    PubMed    


  356. SOFIA MA, Rubin DT
    The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions.
    Dig Dis Sci. 2017;62:833-842.
    PubMed     Abstract available


  357. BENET-CAMPOS C, Cuellar C, Garcia-Ballesteros C, Zamora V, et al
    Determination of Anti-Anisakis Simplex Antibodies and Relationship with alphabeta and gammadelta Lymphocyte Subpopulations in Patients with Crohn's Disease.
    Dig Dis Sci. 2017;62:934-943.
    PubMed     Abstract available


  358. CAO Y, Ding Z, Han C, Shi H, et al
    Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2017;62:851-860.
    PubMed     Abstract available


  359. KAUNITZ JD
    Development of Monoclonal Antibodies: The Dawn of mAb Rule.
    Dig Dis Sci. 2017;62:831-832.
    PubMed    


    March 2017
  360. ALLEGRETTI JR, Barnes EL, Stevens B, Storm M, et al
    Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab.
    Dig Dis Sci. 2017 Mar 29. doi: 10.1007/s10620-017-4549.
    PubMed     Abstract available


  361. BENGTSON MB, Martin CF, Aamodt G, Vatn MH, et al
    Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort.
    Dig Dis Sci. 2017 Mar 22. doi: 10.1007/s10620-017-4547.
    PubMed     Abstract available


  362. KHAN N, Patel D, Shah Y, Yang YX, et al
    A Novel Model for Predicting Incident Moderate to Severe Anemia and Iron Deficiency in Patients with Newly Diagnosed Ulcerative Colitis.
    Dig Dis Sci. 2017 Mar 11. doi: 10.1007/s10620-017-4512.
    PubMed     Abstract available


  363. ARGUELLES-ARIAS F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, et al
    Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
    Dig Dis Sci. 2017 Mar 9. doi: 10.1007/s10620-017-4511.
    PubMed     Abstract available


  364. CARR RM, Patel A, Bownik H, Oranu A, et al
    Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4495.
    PubMed     Abstract available


  365. BOLTIN D, Kamenetsky Z, Perets TT, Snir Y, et al
    Circulating Bone Marrow-Derived CD45-/CD34+/CD133+/VEGF+ Endothelial Progenitor Cells in Adults with Crohn's Disease.
    Dig Dis Sci. 2017;62:633-638.
    PubMed     Abstract available


  366. DIETRICH C, Singh SR
    Circulating Endothelial Progenitor Cells in Crohn's Disease: An EPiC in the Making?
    Dig Dis Sci. 2017;62:567-568.
    PubMed    


  367. TRIADAFILOPOULOS G, Eisenstat S, Dormady S, Sinha R, et al
    When It Rains It Pours: Evolving, Complicated Small Intestinal Crohn's Disease.
    Dig Dis Sci. 2017;62:577-582.
    PubMed    


    February 2017
  368. RAI T, Choudhury BN, Kedia S, Bopanna S, et al
    Short-Term Clinical Response to Corticosteroids Can Predict Long-Term Natural History of Ulcerative Colitis: Prospective Study Experience.
    Dig Dis Sci. 2017 Feb 4. doi: 10.1007/s10620-017-4450.
    PubMed     Abstract available


  369. NARULA N, Cooray M, Anglin R, Muqtadir Z, et al
    Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn's Disease in Remission: A Pilot Randomized Double-Blind Controlled Study.
    Dig Dis Sci. 2017;62:448-455.
    PubMed     Abstract available


  370. BODELIER AG, Jonkers D, van den Heuvel T, de Boer E, et al
    High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.
    Dig Dis Sci. 2017;62:465-472.
    PubMed     Abstract available


  371. KOTZE PG, Saab MP, Saab B, da Silva Kotze LM, et al
    Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.
    Dig Dis Sci. 2017;62:456-464.
    PubMed     Abstract available


    January 2017
  372. SCAIOLI E, Sartini A, Liverani E, Digby RJ, et al
    Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch-Anal Anastomosis for Ulcerative Colitis.
    Dig Dis Sci. 2017 Jan 21. doi: 10.1007/s10620-017-4454.
    PubMed     Abstract available


  373. LEE HS, Lim YJ, Shim KN, Moon CM, et al
    Diagnostic Value of Small Bowel Capsule Endoscopy in Isolated Ileitis: A CAPENTRY Study.
    Dig Dis Sci. 2017;62:180-187.
    PubMed     Abstract available


  374. SRIDHAR A, Cwiak CA, Kaunitz AM, Allen RH, et al
    Contraceptive Considerations for Women with Gastrointestinal Disorders.
    Dig Dis Sci. 2017;62:54-63.
    PubMed     Abstract available


  375. STEVENS BW, Borren NZ, Velonias G, Conway G, et al
    Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2017;62:197-206.
    PubMed     Abstract available


  376. FORTINSKY KJ, Kevans D, Qiang J, Xu W, et al
    Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease.
    Dig Dis Sci. 2017;62:188-196.
    PubMed     Abstract available


  377. XIE M, Qin H, Luo Q, He X, et al
    Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.
    Dig Dis Sci. 2017;62:115-123.
    PubMed     Abstract available


  378. REGALIA K, Shelton A, Berry G, Triadafilopoulos G, et al
    Pulmonary Crohn's Disease.
    Dig Dis Sci. 2017;62:64-67.
    PubMed    


    December 2016
  379. TAKAHARA I, Takeshima F, Ichikawa T, Matsuzaki T, et al
    Prevalence of Restless Legs Syndrome in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4420.
    PubMed     Abstract available


  380. KORELITZ BI
    Enduring Value of Thiopurines for Inflammatory Bowel Disease Therapy.
    Dig Dis Sci. 2016 Dec 26. doi: 10.1007/s10620-016-4419.
    PubMed    


  381. TAN MC, El-Serag HB, Hou JK
    Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016 Dec 23. doi: 10.1007/s10620-016-4414.
    PubMed     Abstract available


  382. BERNSTEIN GR, Pickett-Blakely O
    De Novo Inflammatory Bowel Disease After Bariatric Surgery: A Case Series and Literature Review.
    Dig Dis Sci. 2016 Dec 23. doi: 10.1007/s10620-016-4412.
    PubMed    


  383. TAXONERA C, Iglesias E, Munoz F, Calvo M, et al
    Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  384. FEUERSTEIN JD, Sehgal P, Rao V, Malladi VR, et al
    Inflammatory Bowel Disease-Related Abstracts Presented at National Conferences in the USA Are Frequently Unpublished as Full Manuscripts.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  385. WANNHOFF A, Rupp C, Friedrich K, Knierim J, et al
    Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    November 2016
  386. PRIEUX-KLOTZ C, Nahon S, Amiot A, Sinayoko L, et al
    Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  387. LOPEZ-SANROMAN A, Carpio D, Calvet X, Romero C, et al
    Perceived Emotional and Psychological Impact of Ulcerative Colitis on Outpatients in Spain: UC-LIFE Survey.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    October 2016
  388. PADHAN RK, Kedia S, Garg SK, Bopanna S, et al
    Long-Term Disease Course and Pregnancy Outcomes in Women with Inflammatory Bowel Disease: An Indian Cohort Study.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  389. LATUSHKO A, Ghazi LJ
    A Case of Thiopurine-Induced Acute Myocarditis in a Patient with Ulcerative Colitis.
    Dig Dis Sci. 2016.
    PubMed    


  390. COLOM-STEELE D, Castresana D, Hanson J, Parasher G, et al
    A Rare Case of Invasive Pancreatitis in an Immunocompromised Host.
    Dig Dis Sci. 2016.
    PubMed    


    September 2016
  391. BARNES EL, Goldin A, Winter RW, Collins E, et al
    Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  392. SUSKIND DL, Wahbeh G, Cohen SA, Damman CJ, et al
    Patients Perceive Clinical Benefit with the Specific Carbohydrate Diet for Inflammatory Bowel Disease.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  393. ANDERSON AJ, Click B, Ramos-Rivers C, Babichenko D, et al
    Development of an Inflammatory Bowel Disease Research Registry Derived from Observational Electronic Health Record Data for Comprehensive Clinical Phenotyping.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    April 2016
  394. LIU JJ, Kay TM, Davis EM, Lou Y, et al
    Epithelial Cell Extrusion Zones Observed on Confocal Laser Endomicroscopy Correlates with Immunohistochemical Staining of Mucosal Biopsy Samples.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  395. LEE D, Suskind D
    Individualized Food-Based Dietary Therapy for Crohn's Disease: Are We Making Progress?
    Dig Dis Sci. 2016;61:958-60.
    PubMed    


    March 2016
  396. PAUL S, Shuja A, Tam I, Kim EM, et al
    Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: